Program Leadership

Photo of George M. Abraham, MD, MPH, FACP, FIDSA

George M. Abraham, MD, MPH, FACP, FIDSA

Chief of Medicine

Dr. George M. Abraham is Chief of Medicine at Saint Vincent Hospital, Worcester, Massachusetts, a Professor of Medicine at the University of Massachusetts Medical School, and Adjunct Professor at the Massachusetts College of Pharmacy and Health Sciences (MCPHS). He is board certified in Internal Medicine and Infectious Disease.

He is the President (2021-22) of the American College of Physicians (the largest internal medicine specialty organization in the world), having served as the Emeritus Chair of the Board of Governors and a Regent of the College prior. He served as the Governor of the Massachusetts Chapter of the American College of Physicians (ACP) from 2014-18 and as Chair of the Board of Governors from 2018-19. Recently, he was awarded a Mastership in the College.

He is the Chair Emeritus of the Infectious Disease Board of the American Board of Internal Medicine, which is tasked with certifying all subspecialists in the field of infectious disease.

Dr. Abraham is also the Immediate-Past Chair of the Board of Registration (Licensing) in Medicine, Massachusetts (appointed by Governor Deval M. Patrick and reappointed by Governor Charles D. Baker). Prior to this, he has served as a Trustee of the Massachusetts Medical Society (owner of the New England Journal of Medicine), as President of the Worcester District Medical Society, as the Chief Medical Officer of the Central Massachusetts Independent Physician Association and Chair of the Board of Directors of the Health Foundation of Central Massachusetts.

He has received several awards including the AOA Volunteer Faculty Award and the Outstanding Primary Care Educator Award of UMass Medical School; the Leadership Award of the MA chapter of the ACP; and the Phi Lambda Sigma honorary Membership, MCPHS, Worcester, Massachusetts, Saint Vincent Hospital Physician of the Year 2015, among others. Most recently, he was awarded the John H. Clarke Leadership Award by the Federation of State Medical Boards.

His research interests include hepatitis C and B disease, travel medicine and infection control, as well as medication safety and systems improvement. He has authored over 100 publications, abstracts and book chapters, and is an invited speaker at national and international meetings.

Dr. Abraham earned his medical degrees from the Christian Medical College, Ludhiana, India, completed his residency and chief residency at Saint Vincent Hospital, and received his master’s degree in public health from the Johns Hopkins Bloomberg School of Public Health.

Selected Bibliography (recent):

  1. Li Y, Spooner L, Abraham GM.All In The Name Of Vanity: An Unanticipated Outcome of Mycobacterium abscessus infection.Infect Dis Clin Pract 2018;26: 366–368 doi: 10.1097/IPC.0000000000000597
  2. Li Y, George A, Arnaout S, Wang JP, Abraham GM. Splenic infarction: an under-recognized complication of infectious mononucleosis? Open For Inf Dis 17 Feb 2018
  3. Lal A, Trivedi N, Abraham GM. From Famine to a Feast: Little Endogenous Thyroxine to Overproduction. AACE Clin Case Rep Vol 4 No. 5 Sept/Oct 2018 e379 DOI: 10.4158/ACCR-2017-0245.
  4. Lal A, Akhtar J, Isaac S, Mishra AK, Khan MS, Noreldin M, Abraham GM. Unusual cause of chest pain, Bornholm disease, a forgotten entity; case report and review of literature.Resp Med Case Rep 2018 (accepted for publication).
  5. Lal A, Akhtar J, Ullah A, Abraham GM.First Case of Pleural Empyema Caused by Staphylococcus simulans: Review of the Literature.Case Reports in Infectious Diseases. Volume 2018, Article ID 7831284.
  6. Lal A, Davaro R, Mishra AK, Sahu KK, Abraham GM. Detection of coexisting toxigenic Clostridium difficile and nontyphoidal Salmonella in a healthcare worker with diarrhea: A therapeutic dilemma. J Family Med Prim Care 2019;8:2724-7DOI: 10.4103/jfmpc.jfmpc_227_19
  7. Sahu KK, Mishra AK, Lal A, Siddiqui AD, Abraham GM. From Oncologist’s Desk: Hemato-Oncological Aspect of Using Vaporizers, E-Cigarettes, and Other Electronic Nicotine Delivery Systems (ENDS). Indian J Hematol Blood Transfus published online 6 Sep 2019
  8. Lal, A, Abraham GM. Utility of CD4 Cell Count and Viral Load Assay in Hospitalized Patients with Known HIV Infection: High Value Care Exercise. Infect Disord Drug Targets. DOI: 10.2174/1871526519666191011162018
  9. Lal A, Mishra AK, Sahu KK, Abraham GM. Machine Learning and Patient Expectations: Potential Point of Disconnect. Am J Med. 2019 Oct;132(10):e750
  10. Gilvaz V, Abraham GM, Radhakrishnan S, Hashmath Z. From Admission to Discharge, How Artificial Intelligence Could Optimize Patient Care: A Brief Review. American Journal of Hospital Medicine. 2019.3.10.24150/ajhm/2019.016.
  11. Sahu KK, Mishra AK, Lal A, Abraham GM. A double-edged sword: E-cigarettes, and other electronic nicotine delivery systems (ENDS). Internal and Emergency Medicine
  12. Sahu KK, Mishra AK, Lal A, Abraham GM. Mycobacterium avium complex: A rare cause of pancytopenia in HIV infection. J Microsc Ultrastruct 2019;8:27-30
  13. Sullivan KM, Nicolas SE, Burton SJ, Spooner, LM, Kanaan AO, Abraham GM. Innovative approach for sustaining an institutional medication safety committee. Am J Health Syst Pharm. 2020; 77 (11): 826-9
  14. Lal A, Mishra AK, Sahu KK, Abraham GM. The return of Koch's: Ineffective treatment or re-infection. Enferm Infecc Microbiol Clin. 2020 Mar;38 (3):144-145
  15. Sahu KK, Mishra AK, Patel R, Suramaethakul N, Abraham GM. Fungal empyema thoracis. QJM: An International Journal of Medicine, hcaa036.
  16. Abraham GM, Morton JB, Saravolatz LD.Baloxavir: A Novel Antiviral Agent in the Treatment of Influenza. Clinical Infectious Disease 2020 July. doi/10.1093/cid/ciaa107/5722404

PUBLICATIONS (Collaborative/National Task Force)

  1. Qaseem A, Yost J, Etxeandia-Ikobaltzeta I, Miller M, Abraham GM, Obley AJ, Forciea MA, Jokela JA, Humphrey LL for the Scientific Medical Policy Committee of the American College of Physicians.Should Clinicians Use Chloroquine or Hydroxychloroquine Alone or in Combination With Azithromycin for the Prophylaxis of Treatment of COVID-19? Living Practice Points from the American College of Physicians (Version 2).
  2. Qaseem A, Yost J, Etxeandia-Ikobaltzeta I, Miller M, Abraham GM, Obley AJ, Forciea MA, Jokela JA, Humphrey LL for the Scientific Medical Policy Committee of the American College of Physicians.Use of N95, Surgical, and Cloth Masks to Prevent COVID-19 in Health Care and Community Settings: Living Practice Points from the American College of Physicians. Living Practice Points from the American College of Physicians (Version 1).

Research Projects (recent):

  • Mino-Lok™ (Minocycline-EDTA in 19.5% w/v [25% v/v] Ethanol) Catheter Lock Solution. Leonard-Meron Biosciences, Inc. Primary Investigator (local).
  • A Phase 3, randomized, double-blind, active controlled study to compare the efficacy and safety of ridinilazole (200 mg, bid) for 10 days with vancomycin (125 mg, qid) for 10 days in the treatment of Clostridium difficile infection (CDI). Summit (Oxford, UK). Primary Investigator (local).